Log in Book a Demo

US Pharma & Biotech Pulmonology - PPC Market Share Analysis June 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pulmonology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Pulmonology – US

Google AI Overview visibility for Pharma & Biotech Pulmonology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 70.9338807762
29.0661192238
70%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 16
84
16%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 5%
Navigational 0%
Seasonal 0%
Local 0%
Problem Solving 29%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pulmonology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
breztri.com 25.56
dupixenthcp.com 12.59
dupixent.com 11.74
breztrihcp.com 8.94
yupelrihcp.com 7.37
zoryvehcp.com 4.62
tezspire.com 3.53
yupelri.com 3.26
houstonmethodist.org 2.71
copdfoundation.org 2.65
others 17.03
  • breztri.com - 25.56%
  • dupixenthcp.com - 12.59%
  • dupixent.com - 11.74%
  • breztrihcp.com - 8.94%
  • yupelrihcp.com - 7.37%
  • zoryvehcp.com - 4.62%
  • tezspire.com - 3.53%
  • yupelri.com - 3.26%
  • houstonmethodist.org - 2.71%
  • copdfoundation.org - 2.65%
  • others - 17.03%

Copyright © Adthena. All rights reserved.

In the PPC landscape, breztri.com leads with 25.56% click share, followed by dupixenthcp.com at 12.59%. ‘Others’ collectively hold 17.03%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pulmonology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date breztri.com dupixent.com dupixenthcp.com breztrihcp.com yupelrihcp.com tezspire.com trelegy.com zoryvehcp.com copdfoundation.org yupelri.com
2026/05/01 33.32% 17.16% 11.03% 3.5% 2.95% 4.68% 2.54% 4.91% 2.06% 1.96%
2026/05/02 27.13% 14.56% 12.6% 13.28% 4.14% 4.12% 2.37% 1.9% 2.21% 5.15%
2026/05/03 35.88% 10.75% 12.61% 3.33% 5.34% 7.23% 1.92% 2.16% 1.27% 5%
2026/05/04 29.59% 13.75% 14.65% 14.33% 8.01% 3.16% 1.47% 1.77% 0.14% 5.39%
2026/05/05 31.06% 10.27% 11.29% 15.04% 6.34% 5.66% 1.58% 2.37% 0.7% 3.01%
2026/05/06 43.32% 10.82% 9.75% 17.39% 5.61% 1.01% 1.86% 1.04% 0.69% 3.38%
2026/05/07 42.13% 11.03% 9.88% 19.48% 3.85% 1.95% 1.97% 0% 0.32% 4.05%
2026/05/08 26.31% 13.6% 15.41% 4.43% 4.74% 2.04% 1.86% 9.55% 2.14% 3.05%
2026/05/09 37.22% 9.08% 11.63% 18.05% 5.99% 0.8% 2.46% 0% 1.89% 4.89%
2026/05/10 15.13% 5.58% 7.24% 8.15% 2.33% 0.69% 1.9% 0% 1.15% 2.29%
2026/05/11 25.03% 6.73% 14.67% 6.15% 6.03% 0.53% 0.85% 4.28% 5.14% 3.43%
2026/05/12 30.75% 6.04% 19.42% 9.79% 6.99% 0.75% 1.61% 3.72% 1.47% 4.95%
2026/05/13 32.66% 5.14% 14.72% 9.92% 9.26% 0.19% 2.79% 6.49% 0.43% 5.45%
2026/05/14 23.15% 11.11% 17.64% 13.12% 6.92% 4.39% 1.37% 1.97% 0.74% 4.43%
2026/05/15 26.29% 13.58% 15.4% 4.54% 4.74% 2.04% 1.86% 9.54% 2.14% 3.04%
2026/05/16 20.41% 8.73% 18.26% 12.91% 6.94% 8.28% 4.47% 2.25% 2.62% 4.3%
2026/05/17 26.4% 12.26% 18.45% 4.06% 8.43% 8.45% 2.48% 2.13% 2.33% 5.85%
2026/05/18 30.73% 8.84% 11.07% 6.3% 6.61% 4.39% 4.16% 10.11% 1.04% 4.85%
2026/05/19 28.82% 14.76% 14.05% 3.56% 6.07% 10.01% 3.05% 3.62% 1.73% 3.43%
2026/05/20 21.91% 7.99% 15.11% 10.65% 5.12% 8.68% 2.46% 6.63% 3.07% 3.82%
2026/05/21 19.27% 11.07% 14.68% 6.4% 4.18% 7.2% 4.22% 7.98% 7.08% 4.67%
2026/05/22 22.77% 12.4% 16.84% 12.99% 3.87% 0.99% 1.52% 3.57% 3.15% 3.63%
2026/05/23 26.19% 10.99% 12.8% 5.88% 10.48% 3.17% 2.72% 2.61% 3.63% 7.94%
2026/05/24 21.2% 18.2% 10.41% 5.58% 7.51% 8.14% 4.18% 7.94% 0.93% 5.04%
2026/05/25 26.16% 10.77% 8.78% 11.13% 4.2% 5.41% 1.53% 7.78% 10.08% 2.37%
2026/05/26 28.61% 8.88% 8.27% 13.49% 7.98% 2.83% 3.42% 5.55% 0.79% 6.7%
2026/05/27 25.91% 8.37% 17.4% 4.16% 10.27% 0.24% 4.95% 7.54% 1.48% 4.76%
2026/05/28 28.51% 15.15% 15.06% 5.55% 8.61% 1.51% 1.43% 3.04% 4.89% 1.28%
2026/05/29 18.5% 13.53% 15.66% 6.98% 14.09% 4.91% 3.17% 0% 2.18% 1.44%
2026/05/30 24.51% 14.99% 12.39% 12.5% 11.13% 4.26% 1.57% 0% 4.4% 1.27%
2026/05/31 24.81% 13.81% 9.69% 9.25% 7.34% 6.97% 5.1% 3.04% 3.01% 0.07%
  • breztri.com
  • dupixent.com
  • dupixenthcp.com
  • breztrihcp.com
  • yupelrihcp.com
  • tezspire.com
  • trelegy.com
  • zoryvehcp.com
  • copdfoundation.org
  • yupelri.com

Copyright © Adthena. All rights reserved.

In May 2026, Breztri.com led with fluctuating spend, peaking at 43.32% on May 6. Dupixent.com maintained a steady presence, while Dupixenthcp.com showed consistent mid-range values. Breztrihcp.com and Yupelrihcp.com had notable spikes, with Tezspire.com and Trelegy.com showing varied trends. Zoryvehcp.com and Copdfoundation.org had sporadic increases, while Yupelri.com ended with a decline.

Market Exposure

Competitor Count for US Pharma & Biotech Pulmonology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/05/01 24
2026/05/02 26
2026/05/03 23
2026/05/04 25
2026/05/05 24
2026/05/06 23
2026/05/07 19
2026/05/08 24
2026/05/09 26
2026/05/10 29
2026/05/11 30
2026/05/12 33
2026/05/13 29
2026/05/14 32
2026/05/15 24
2026/05/16 33
2026/05/17 26
2026/05/18 29
2026/05/19 26
2026/05/20 29
2026/05/21 31
2026/05/22 26
2026/05/23 28
2026/05/24 27
2026/05/25 31
2026/05/26 29
2026/05/27 31
2026/05/28 30
2026/05/29 28
2026/05/30 30
2026/05/31 31

Copyright © Adthena. All rights reserved.

In May 2026, advertiser numbers fluctuated, starting at 24, peaking at 33 mid-month, and concluding at 31, indicating a dynamic advertising landscape.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pulmonology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
yupelrihcp.com 2.4%
zoryvehcp.com 2.25%
trelegyhcp.com 2.05%
copdfoundation.org 2.02%
dupixent.com 1.91%
dupixenthcp.com -0.97%
mayoclinic.org -1.36%
breztrihcp.com -2.42%
breztri.com -4.69%
houstonmethodist.org -5.84%

Copyright © Adthena. All rights reserved.

In the past month, yupelrihcp.com surged by 2.40%, while houstonmethodist.org dropped by 5.84%.

Campaign Efficiency

US Pharma & Biotech Pulmonology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date breztri.com dupixent.com yupelrihcp.com dupixenthcp.com breztrihcp.com tezspire.com zoryvehcp.com copdfoundation.org zoryve.com yupelri.com
2026/05/01 23.46% 18.72% 4.63% 10.04% 3.46% 6.14% 9.52% 2.86% 0% 1.64%
2026/05/02 23.74% 15.94% 5.82% 11.68% 12.31% 5.23% 4.11% 2.12% 4.11% 4.12%
2026/05/03 29.52% 12.51% 5.77% 10.95% 5.66% 9.31% 4.58% 1.23% 0% 3.83%
2026/05/04 22.24% 16.73% 10.09% 12.07% 17.16% 4.59% 3.59% 0.13% 0% 4.76%
2026/05/05 21.41% 11.05% 8.03% 10.06% 18.93% 7.92% 4.67% 0.59% 0% 2.62%
2026/05/06 38.13% 12.21% 6.91% 9.18% 20.97% 1.47% 2.07% 0.61% 0% 2.9%
2026/05/07 38.5% 11.91% 4.64% 9.62% 22.64% 2.71% 0% 0.32% 0% 3.43%
2026/05/08 19.06% 12.56% 5.77% 13.62% 4.42% 2.34% 17.51% 2.59% 4.38% 2.25%
2026/05/09 34.85% 8.75% 6.69% 11.39% 20% 1.07% 0% 2.25% 3.98% 3.98%
2026/05/10 18.62% 8.18% 4.28% 10.44% 11.24% 1.28% 0% 1.81% 4.18% 2.77%
2026/05/11 20.34% 6.05% 5.72% 11.66% 5.92% 0.65% 7.42% 4.82% 4.95% 2.45%
2026/05/12 25.01% 6.01% 6.89% 17.91% 10.21% 0.92% 6.5% 1.41% 6.5% 3.74%
2026/05/13 24.87% 6.61% 13.07% 13.38% 9.06% 0.12% 11.44% 0.36% 7.63% 3.79%
2026/05/14 16.8% 10.8% 8.28% 18.02% 12.1% 5.45% 4.17% 0.57% 0% 3.46%
2026/05/15 19.06% 12.56% 5.77% 13.62% 4.42% 2.34% 17.51% 2.59% 4.38% 2.25%
2026/05/16 14.86% 10.45% 6.29% 19.32% 16.52% 10.04% 4% 2.24% 0% 3.3%
2026/05/17 22.72% 13.51% 8.42% 19.34% 3.43% 10.54% 4.5% 1.95% 4.5% 4.45%
2026/05/18 25.77% 10.47% 6.31% 8.01% 6.58% 5.89% 19.09% 1.14% 0% 3.95%
2026/05/19 20.81% 18.95% 6.04% 13.64% 2.86% 13.7% 8.58% 2.02% 0% 2.95%
2026/05/20 15.62% 9.76% 5.72% 12.37% 10.41% 9.51% 12.05% 2.71% 4.02% 2.69%
2026/05/21 14.23% 11.46% 4.02% 14.2% 5.43% 8.1% 14.72% 7.1% 5.89% 3.41%
2026/05/22 16.04% 12.56% 4.55% 15.8% 10.38% 1.03% 6.55% 3.57% 16.38% 2.73%
2026/05/23 24.65% 11.12% 10.38% 11.48% 5.56% 3.27% 4.17% 3.04% 8.35% 5.53%
2026/05/24 16.48% 21.33% 8.58% 11.29% 4.48% 9.6% 13.83% 1.39% 0% 3.85%
2026/05/25 18.05% 11.34% 5.66% 7.98% 8.64% 6.33% 13.65% 7.61% 5.46% 1.83%
2026/05/26 18.95% 10.06% 8.36% 8.38% 11.91% 3.6% 12.21% 0.78% 0% 5.38%
2026/05/27 22.7% 7.87% 12.32% 13.98% 2.84% 0.15% 13.56% 1.15% 3.39% 3.37%
2026/05/28 25.62% 14.79% 11.35% 14.06% 5.41% 1.67% 5.74% 4.91% 0% 0.99%
2026/05/29 13.51% 14.42% 16.74% 12.87% 8.09% 6.11% 0% 3.95% 0% 1.16%
2026/05/30 17.6% 15.9% 17.59% 13.48% 11.4% 5.23% 0% 4.41% 0% 1.02%
2026/05/31 20.35% 13.26% 9.87% 9.18% 8.74% 7.48% 5.18% 3.45% 3.45% 0.05%
  • breztri.com
  • dupixent.com
  • yupelrihcp.com
  • dupixenthcp.com
  • breztrihcp.com
  • tezspire.com
  • zoryvehcp.com
  • copdfoundation.org
  • zoryve.com
  • yupelri.com

Copyright © Adthena. All rights reserved.

In May 2026, Breztri.com led with fluctuating impressions, peaking at 38.50%. Dupixent.com saw a decline, while Yupelrihcp.com and Dupixenthcp.com showed varied trends. The month ended with Breztri.com maintaining dominance.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology - Last month
  1. 1
    Inhaler Treatment Option - Learn How This Treatment Works https://www.breztri.com/

    BREZTRI AEROSPHERE® (budesonide/glycopyrrolate/formoterol fumarate) Patient Site.

  2. 2
    Triple Therapy Inhaler - Get The Facts About This Drug https://www.breztrihcp.com/

    BREZTRI AEROSPHERE® (budesonide/glycopyrrolate/formoterol fumarate) - View Treatment Info.

  3. 3
    Lung Disease Treatment - Advanced Diagnosis & Treatment https://www.mayoclinic.org

    See Experts with Extensive Experience in Diagnosing & Treating Lung Disease. Research-Applied Care.

  4. 4
    Severe Asthma Medication - Official Patient Site Prescription treatment website

    If Your Asthma Medication Isn't Providing Relief, Consider An Add-On Treatment Option.

  5. 5
    ZORYVE® (roflumilast) - For Healthcare Professionals https://www.zoryvehcp.com/formulation

    Review the formulation information. See if it may be right for your patients. View information and resources intended for healthcare professionals.

Copyright © Adthena. All rights reserved.

In the competitive landscape of PPC ads, Breztri dominates with dual sites emphasizing inhaler treatments and triple therapy. Mayo Clinic highlights expertise in lung disease care, while Tezspire and Zoryve focus on severe asthma and healthcare professional resources, respectively.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.